Phencyclidine produces changes in NMDA and kainate receptor binding in rat hippocampus over a 48-hour time course

Synapse

Volumn 23, Issue 4, 1996, Pages 274-279

  Gao, Xue Min ^a   Tamminga, Carol A ^a  

^a MARYLAND PSYCHIATRIC RESEARCH CENTER   (United States)

Author keywords

Hippocampus; Limbic system; Phencyclidine; Psychosis; Receptor binding; Schizophrenia

Indexed keywords

DIZOCILPINE; GLUTAMATE RECEPTOR; KAINIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID; PHENCYCLIDINE; RECEPTOR SUBTYPE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN METABOLISM; CAUDATE NUCLEUS; CONTROLLED STUDY; DRUG EFFECT; DRUG RECEPTOR BINDING; ENTORHINAL CORTEX; HIPPOCAMPUS; LIMBIC SYSTEM; MALE; NONHUMAN; NUCLEUS ACCUMBENS; PARIETAL LOBE; PREFRONTAL CORTEX; PRIORITY JOURNAL; PSYCHOSIS; RAT; RECEPTOR DENSITY; SCHIZOPHRENIA;

ANALYSIS OF VARIANCE; ANIMALS; BRAIN; DOSE-RESPONSE RELATIONSHIP, DRUG; EXCITATORY AMINO ACID ANTAGONISTS; HALLUCINOGENS; HIPPOCAMPUS; MALE; PHENCYCLIDINE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, KAINIC ACID; RECEPTORS, N-METHYL-D-ASPARTATE; TIME FACTORS;

EID: 0029831003     PISSN: 08874476     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2396(199608)23:4<274::AID-SYN5>3.0.CO;2-4     Document Type: Article

References (31)

1. Albin, R.L., Makowiec, R.L., Hollingsworth, Z., Dure, L.S., Penney, J.B., and Young, A.B. (1990) Excitatory amino acid binding sites in the periaquaductal gray of the rat. Neurosci. Lett., 118:112-115.
2. Allen, R.M., and Young, S.J. (1978) Phencyclidine-induced psychosis. Am. J. Psychiatry, 135:1081-1084.
3. Anis, N.A., Berry, S.C., Burton, N.R., and Lodge, D. (1983) The dissociative anesthetics ketamine and phencyclidine, selectively reduce excitation of central mammalian neurons by N-methyl-aspartate. Br. J. Pharmacol., 79:565-575.
4. Cotman, C.W., Monaghan, D.T., Ottersen, O.P., and Storm-Mathisen, J. (1987 ) Anatomical organization of excitatory amino acid receptors and their pathways. TINS, 10:273-280.
5. Du, F., and Schwarcz, R. (1992) Aminooxyacetic acid causes selective neuronal loss in layer III of the rat medial enthorhinal cortex. Neurosci. Lett., 147:185-188.
6. Domino, E.F. (1980) History and pharmacology of PCP and PCP-related analogs. J. Psychoact. Drugs, 12:223-227.
7. Gao, X.M., and Tamminga, C.A. (1994) An increase in NMDA-sensitive 3H-glutamate and 3H-kainate binding in hippocampus at 24 hours after PCP. Neurosci. Lett., 174:149-153.
8. Gao, X.M., and Tamminga, C.A. (1995) MK801 induced late regional increase in NMDA and kainate receptor binding in rat brain. J Neural Transm., (in press).
9. Gao, X.M., Shirakawa, O., Du, F., and Tamminga, C.A. (1993) Delayed phencyclidine-induced alterations in local cerebral glucose utilization. Eur. J. Pharmacol., 241:7-15.
10. Greenamyre, J.T., Olson, J.M.M., Penney, J.B., Jr., and Young, A.B. (1985) Autoradiographic characterization of N-methyl-D-aspartate-, quisqualate- and kainate-sensitive glutamate binding sites. J. Pharmacol. Exp. Ther., 233:254-263.
11. Harris, E.W., Ganong, A.H., and Cotman, C.W. (1984) Long term potentiation in the hippocampus involves activation of N-methyl-D-aspartate receptors. Brain Res., 323:132-137.
12. Honey, C.R., Miljkovic, Z., and MacDonald, J.F. (1985) Ketamine and phencyclidine cause a voltage-dependent block of responses to Laspartic acid. Neurosci. Lett., 61:135-139.
13. Javitt, D.C., and Zukin, S.R. (1991) Recent advances in the phencyclidine model of schizophrenia. Am. J. Psychiatry, 148:1301-1309.
14. Kakigi, T., Gao, X-M., Shirakawa, O., and Tamminga, C.A. (1992) Chronic haloperidol treatment reduces glutamate receptor binding in limbic structures of rat brain. Neurosci. Abst., 18:377.
15. Kirk, R.E. (1982) Experimental Design: Procedures for the Behavioral Sciences. Second Edition, Brooks/Cole Publishing Company, Wadsworth, Inc., Belmont, California.
16. Krystal, J.H., Karpe, L.P., Seibyl, J.P., Freeman, G.K., Delaney, R., Bremner, D., Heninger, G.R., Bowers, M.B., and Charney, D.S. (1994) Subanesthetic effects of noncompetitive NMDA antagonist, ketamine, in humans: Psychotomimetic, perceptual cognitive, and neuroendocrine responses. Arch. Gen. Psychiatry., 51:199-214.
17. Lahti, A.C., Mokriski, D., LaPorte, and Tamminga, C.A. (1995) Subanesthetic doses of ketamine stimulate psychosis in schizophrenia. Neuropsychopharmacology, (in press).
18. Meltzer, H.Y., Holtzman, P.A., Hassan, S.Z., and Guschwan, A. (1972) Effects of phencyclidine and stress on plasma CPK and aldolase activity in man. Psychopharmacology, 26:44-53.
19. McDonald, J.W., Silverstein, F.S., and Johnston, M.V. (1990) MK801 pretreatment enhances n-methyl-d-aspartate-mediated brain injury and increases brain N-methyl-d-aspartate recognition site binding in rats. Neuroscience, 38:103-113.
20. Monaghan, D.R., Bridges, R.J., and Cotman, C.W. (1989) The excitatory amino acid receptors: Their classes, pharmacology, and distinct properties in the function of the central nervous system. Ann. Rev. Pharmacol. Toxicol., 29:365-402.
21. Olney, J.W., Labruyere, J., and Price, M.T. (1989 ) Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs. Science 244, 1360-1362.
22. Pearlson, G.D. (1981) Psychiatric and medical syndromes with phencyclidine (PCP) abuse. Johns Hopkins Med. J., 148:25-48.
23. Rosenbaum, G., Cohen, B.D., Luby, E., Gottlieb, J.S., and Yelen, D. (1959) Comparison of serenyl with other drugs: stimulation of schizophrenia performance with serenyl, LSD-25, and amylbarbitol (amytal) sodium; I. Attention, motor function, and proprioception. Arch. Gen. Psychiatry, 1:651-656.
24. Sharp, F.R., Butman, M., Wang, S., Koistinaho, J., Graham, S.H., Sagar, S.M., Noble, L., Berger, P., and Longo, F.M. (1992) Haloperidol prevents induction of the hsp70 heat shock gene in neurons injured by phencyclidine (PCP), MK801, and ketamine. J. Neurosci. Res., 33:605-616.
25. Salt, T.E., and Herrling, P.L. (1991) Excitatory amino acid transmitter function in mammalian central pathways. In: Excitatory Amino Acids and Synaptic Transmission. H. Wheal and A. Thomas, eds. Academic Press, London, pp. 155-170.
26. Snell, L.D., and Johnson, K.M. (1985) Antagonism of N-methyl-D-aspartate-induced transmitter release in the rat striatum by phencyclidine-like drugs and its relationship to turning behavior. J. Pharmacol. Exp. Therapeutics 235:50-57.
27. Tamminga, C.A., Tanimoto, K., Kuo, S., Chase, T.N., Contreres, P.C., Rice, K.C., Jackson, A.E., O'Donahue, T.L. (1987) PCP-Induced alterations in cerebral glucose utilization in rat brain. Synapse, 1:497-504.
28. Tamminga, C.A., Gao, X.M., Du, F., and Schwarcz, R. (1994) "Indirect Excitotoxin" lesion of layer III in rat entorhinal cortex produces glutamate receptor changes in hippocampus. Neurosci. Abst., 20: 213.20.
29. 2 receptors in the rat striatum is enhanced by denervation but not by chronic receptor blockade. Neurosci. Lett., 70:245-249.
30. Watkins, J.C., and Collingridge, G.L. (1989) The NMDA Receptor. Oxford University Press, Oxford.
31. Williams, K., Dichter, M.A., and Molinoff, P.B. (1992) Upregulation of N-methyl-D-aspartate receptors on cultured cortical neurons after exposure to antagonists. Molec. Pharmacol., 42:147-151.